home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

7 rows where agency_id = "FDA" and docket_id = "FDA-1999-P-0126" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, posted_date (date), last_modified (date)

posted_year 3

  • 1999 4
  • 2002 2
  • 2000 1

document_type 1

  • Other 7

agency_id 1

  • FDA · 7 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1999-P-0126-0007 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/CDER to GlaxoSmithKline Other PAV-Petition Approval 2002-07-12T04:00:00Z 2002 7     2008-04-25T00:19:51Z   0 0 09000064804ae9f3
FDA-1999-P-0126-0008 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/CDER to Pharmacia & Upjohn Other PAV-Petition Approval 2002-07-12T04:00:00Z 2002 7     2008-04-25T00:19:51Z   0 0 09000064804ae9f5
FDA-1999-P-0126-0006 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/CDER to Pharmacia & Upjohn Other LET-Letter 2000-04-06T04:00:00Z 2000 4     2008-04-25T00:19:51Z   0 0 09000064804ae9f2
FDA-1999-P-0126-0004 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/DMB to Pharmacia & Upjohn Inc. Other CR-Correction 1999-10-26T04:00:00Z 1999 10     2008-04-25T00:19:51Z   0 0 09000064804ae9ee
FDA-1999-P-0126-0003 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/DMB to Pharmacia & Upjohn Other ACK-Acknowledgement Letter 1999-10-26T04:00:00Z 1999 10     2008-04-25T00:19:51Z   0 0 09000064804ae9ed
FDA-1999-P-0126-0002 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/CDER to Glaxo Wellcome Inc Other LET-Letter 1999-09-14T04:00:00Z 1999 9     2008-04-25T00:19:51Z   0 0 09000064804ae9eb
FDA-1999-P-0126-0001 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/DMB to Glaxo Wellcome Incorporated Other ACK-Acknowledgement Letter 1999-03-04T05:00:00Z 1999 3     2008-04-25T00:19:51Z   0 0 09000064804ae9e6

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
Powered by Datasette · Queries took 80.366ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API